Main Street Financial Solutions’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Main Street Financial Solutions’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,804	Closed	-$233K	–	467
2022 Q4	$233K	Buy	+2,804	New	+$227K	0.04%	389
2021 Q2	–	Sell	-1,823	Closed	-$247K	–	457
2021 Q1	$247K	Buy	1,823 +253	+16%	+$37.9K	0.04%	369
2020 Q4	$221K	Buy	+1,570	New	+$201K	0.05%	354

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Main Street Financial Solutions's XBI Position: Q1 2023 in Review

Main Street Financial Solutions sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2023, closing a stake of 2,804 shares — an estimated $233K sold.

Main Street Financial Solutions first reported a position in XBI in Q4 2020 and held it in 3 quarters. The position peaked at $247K in Q1 2021. 712 funds tracked by Wall St. Rank hold XBI as of Q1 2023.

Main Street Financial Solutions reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2023 after selling out during the quarter.
Main Street Financial Solutions sold 2,804 State Street SPDR S&P Biotech ETF shares in Q1 2023, an estimated $233K.
Main Street Financial Solutions first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and held it in 3 quarters.
Main Street Financial Solutions's State Street SPDR S&P Biotech ETF position peaked at $247K in Q1 2021.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2023.

Based on Main Street Financial Solutions's 13F filing for Q1 2023, filed 21 Apr 2023.